Cardiovascular

Cancer survivors are eight times more likely to develop cardiovascular disease than the general population.

  • Breast cancer treatments can affect the heart
  • Some women develop life-threatening heart damage while undergoing chemotherapy, which can cause a condition called cardiotoxicity.


A new heart hub has been established in South Western Sydney that will deliver an impact far beyond NSW. Headed by the world-renowned academic cardiologist and clinical trialist Professor Kazuaki Negishi, the Hub was founded to advance health equity in the treatment and outcomes of a population disproportionately affected by Cardiovascular Disease.

The Hub is a partnership between Ingham Institute for Applied Medical Research, Victor Chang Cardiac Research Institute, UNSW Sydney, and South Western Sydney Local Health District.

 

Key initiatives

  • Early intervention for women with breast cancer who are undergoing chemotherapy
    • Specialised treatment to minimise heart damage due to chemotherapy while their cancer treatment continues
  • Using ultrasound technology to help remove arterial blockages before and after heart surgery
    • Reduces the amount of heart muscle damage after a heart attack by 30%
  • Identifying environmental factors that impact heart disease
    • Air pollution and its link to cardiac arrest
    • The impact of extreme heat on the heart, which disproportionately affects people in lower socio-economic areas such as South Western Sydney
  • Space medicine
    • Training astronauts how to monitor for cardiovascular disease

When you support cardiac research at Ingham Institute, you are helping improve heart health for people in our community and around the world.

Professor Kaz Negishi

Chair, Cardiovascular Research
Ingham Institute

The last thing a woman with breast cancer wants to be told, is that their treatment has to be put on hold. No-one should have to choose between life-saving chemotherapy treatment or life-saving heart treatment.

Professor Kaz Negishi